Clinical trial · Observational
Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer
Integrative Chinese and Western Medicine for Colorectal Cancer: A Nationwide Prospective Cohort Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a nationwide cohort study on integrated traditional Chinese and Western medicine for colorectal cancer. The aim is to elucidate the distribution patterns of TCM syndromes in colorectal cancer and colorectal adenoma, reveal the relationship between TCM syndromes and diagnosis, prognosis, and prognosis. Based on biological samples, a phenotypic omics study of TCM syndromes in colorectal cancer and colorectal adenoma is conducted.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Adenoma | Colorectal Adenoma | ONTOLOGY_EXACT | 0.98 |
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (3)
- label
- Rectal cancer cohort
- description
- 20,000 patients with rectal cancer will be included in this cohort and followed for five years.
- label
- Colon cancer cohort
- description
- 20,000 patients with colon cancer will be included in this cohort and followed for five years.
- label
- Colorectal adenoma cohort
- description
- 10,000 patients with colorectal adenomas will be enrolled in this cohort and followed for five years.
Primary outcomes (2)
- measure
- Overall survival of patients with CRC
- timeFrame
- 5 years
- description
- Patients were recorded from the time they entered the study until their final death.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: CRC patients: 1. The patient is over 18 years old; 2. The patient meets the diagnostic criteria for colorectal cancer; 3. The patient has not received anti-tumor treatment such as surgery, chemotherapy, radiotherapy, targeted therapy, or immunity in the past; 4. The patient voluntarily participated in this study and signed an informed consent form. Colorectal adenoma patients 1. The patient is over 18 years old; 2. The patient meets the diagnostic criteria for colorectal adenoma; 3. The patient voluntarily participated in this study and signed an informed consent form. Exclusion Criteria: CRC patients: 1. Combined with other malignant tumors; 2. The patient has severe cognitive impairment, dementia, and various mental disorders. Colorectal adenoma patients: 1. The patient had a history of malignancy; 2. The patient has severe cognitive impairment, dementia, and various mental disorders.
References
Publications (1)
- DERIVEDHui YF, Song SC, Zhu WJ, Bu S, Sun J, Ling TS, Cheng HB. Multicenter prospective cohort study on colorectal adenoma recurrence and malignant transformation risk based on integrative medicine: a study protocol. Front Oncol. 2025 Oct 27;15:1657390. doi: 10.3389/fonc.2025.1657390. eCollection 2025. PMID 41220937